Worldwide Intravenous Solutions Industry to 2027 - Featuring Ajinomoto, Baxter International and Grifols Among Others

Dublin, May 03, 2022 (GLOBE NEWSWIRE) -- The "Intravenous Solutions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to's offering.

The global intravenous solutions market reached a value of US$ 13.2 billion in 2021. Looking forward, the market is projected to reach US$ 18.6 billion by 2027, exhibiting a CAGR of 5.96% during 2022-2027. Keeping in mind the uncertainties of COVID-19, the analyst is continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Intravenous (IV) solutions are supplemental fluids comprising water, electrolytes, sugar, and medications. They are given to patients according to their requirements, medical condition, age, and body size to restore fluid volume and treat electrolyte balance. At present, they are widely used in IV therapy to replace electrolyte losses, administer drugs and blood products, and supply essential nutrients to the intravascular fluid compartment.

Intravenous Solutions Market Trends

Due to the sudden outbreak of coronavirus disease (COVID-19), there is a rise in the demand for IV solutions worldwide to provide essential nutrients to patients in the intensive care unit (ICU). Apart from this, the increasing number of people who have diabetes, cancer, gastrointestinal disorder, and neurological diseases represents another major growth-inducing factor. Moreover, the faster response time and higher efficacy associated with IV solution therapy is contributing to market growth. It is used to overcome chronic dehydration that can cause fatigue, memory problems, irritability, and other medical conditions.

This, along with the increasing participation of individuals in physical activities, is influencing the adoption of IV solutions for a fast recovery. IV solutions are also utilized to improve skin conditions and treat migraines and hangovers. Besides this, leading manufacturers are introducing easy-to-use, portable product variants that can be used as drips at home. Additionally, due to rising environmental concerns, they are developing premixed solutions that reduce the amount of packaging waste. Furthermore, rising investments by health agencies of numerous countries in the healthcare sector are anticipated to create a favorable market outlook.

Key Market Segmentation

This report provides an analysis of the key trends in each sub-segment of the global intravenous solutions market, along with forecasts at the global and regional level from 2022-2027. The report has categorized the market based on type and nutrients.

Breakup by Type:

  • Partial Parenteral Nutrition
  • Total Parenteral Nutrition

Total parenteral nutrition is currently the most preferred type of IV solution as it helps prevent malnutrition and maintain energy.

Breakup by Nutrients:

  • Carbohydrates
  • Salts and Electrolytes
  • Minerals
  • Vitamins
  • Amino Acids

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Presently, North America enjoys the leading position in the market due to the increasing prevalence of chronic diseases in the region.

Competitive Landscape

The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are Ajinomoto Co., Inc., B. Braun Melsungen AG, Baxter International, Inc., Grifols S.A., and Otsuka Pharmaceutical.

Key Questions Answered in This Report
1. What is the expected growth rate of the global intravenous solutions market during 2022-2027?
2. What are the key factors driving the global intravenous solutions market?
3. What has been the impact of COVID-19 on the global intravenous solutions market?
4. What is the breakup of the global intravenous solutions market based on the type?
5. What is the breakup of the global intravenous solutions market based on the nutrients?
6. What are the key regions in the global intravenous solutions market?
7. Who are the key players/companies in the global intravenous solutions market?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Intravenous Solutions Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Type
5.5 Market Breakup by Nutrients
5.6 Market Breakup by Region
5.7 Market Forecast
5.8 SWOT Analysis
5.8.1 Overview
5.8.2 Strengths
5.8.3 Weaknesses
5.8.4 Opportunities
5.8.5 Threats
5.9 Value Chain Analysis
5.9.1 Overview
5.9.2 Research and Development
5.9.3 Raw Material Procurement
5.9.4 Manufacturing
5.9.5 Marketing
5.9.6 Distribution
5.9.7 End-Use
5.10 Porters Five Forces Analysis
5.10.1 Overview
5.10.2 Bargaining Power of Buyers
5.10.3 Bargaining Power of Suppliers
5.10.4 Degree of Competition
5.10.5 Threat of New Entrants
5.10.6 Threat of Substitutes

6 Market Breakup by Type
6.1 Partial Parenteral Nutrition
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Total Parenteral Nutrition
6.2.1 Market Trends
6.2.2 Market Forecast

7 Market Breakup by Nutrients
7.1 Carbohydrates
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Salts and Electrolytes
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Minerals
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Vitamins
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Amino Acids
7.5.1 Market Trends
7.5.2 Market Forecast

8 Market Breakup by Region

9 Intravenous Solutions Manufacturing Process
9.1 Product Overview
9.2 Raw Material Requirements
9.3 Manufacturing Process
9.4 Key Success and Risk Factors

10 Competitive Landscape
10.1 Market Structure
10.2 Key Players
10.3 Profiles of Key Players
10.3.1 Ajinomoto Company Overview Description Product Portfolio Financials SWOT Analysis
10.3.2 B. Braun Melsungen Company Overview Description Product Portfolio Financials SWOT Analysis
10.3.3 Baxter International Inc. Company Overview Description Product Portfolio Financials SWOT Analysis
10.3.4 Grifols Company Overview Description Product Portfolio Financials SWOT Analysis
10.3.5 Otsuka Pharmaceutical Company Overview Description Product Portfolio

For more information about this report visit


Global Intravenous Solutions Market

Contact Data